Associating With Known Aspirin Users.
“We examined the association between aspirin use and breast cancer stratified by early or late stage breast cancer.”
“The dose-response trend in breast cancer incidence associated with increasing use of aspirin was significant among women diagnosed with in situ breast cancer or late stage disease.”
“The strongest inverse associations were observed among the heaviest aspirin users, regardless of stage of disease…”
“Results from this study provide evidence that aspirin use, but not other NSAIDs, may be associated with lower breast cancer risk among postmenopausal women.”
“A clear dose-response trend of decreasing risk of breast cancer incidence with increasing intake of aspirin was observed.”
“The inverse association appears to be limited to some minimum frequency of aspirin use of at least several times per week.”
“This trend remained after adjustment for…other breast cancer risk factors, including…estrogen use, family history of breast cancer,…previous mammography…”
“Reported intake of aspirin six or more times per week compared with no current use was inversely associated with in situ, localized, and late stage breast cancer.”
“Our study is only the second to examine nonaspirin NSAIDs separately from aspirin in relation to breast cancer, and our results for nonaspirin NSAIDs were opposite to those reported previously.”
“The mechanism by which aspirin…may lower the risk of incident breast cancer is not established but has been investigated in cellular and animal studies…shown antitumor effects…and have reduced both the number and size of tumors…even when…given after the exposure to a carcinogen and after microscopic tumors are present.”
With studies like this already published for many years, one would hope for more people to hear about the chemotherapeutic potential of aspirin, and for a far greater amount of funding for further experimentation, to be made available.
See more here
Artist: Melinda Beck “illustration. silhouette style”